Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.108
Bid: 0.103
Ask: 0.1075
Change: -0.00225 (-2.09%)
Spread: 0.0045 (4.369%)
Open: 0.106
High: 0.108
Low: 0.105
Prev. Close: 0.1075
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Flux Footwear to launch graphene enhanced shoe

22 Feb 2022 07:00

RNS Number : 3449C
Versarien PLC
22 February 2022
 

Reach - Non-Regulatory

22 February 2022

Versarien Plc

("Versarien" or the "Company")

Flux Footwear to launch shoe enhanced by Versarien's graphene technology

Versarien (AIM: VRS), the advanced materials engineering group, is pleased to announce that, following a collaboration with US-based Flux Footwear LLC ("Flux"), an adaptive footwear company, the Company will be supplying graphene enhanced elastomers to Flux to bring an improved model of Flux's 'Adapt' shoe, the 'AdaptMid', to market.

Under the terms of the partnership, the 'Adapt' barefoot athleisure model has been enhanced with Versarien's Graphene-Wear™ technology, following research and testing to improve the rubber outsole, augmenting the shoe's mechanical and physical properties. The new model, the 'AdaptMid', provides greater durability through improved abrasion resistance whilst maintaining the shoe's traction characteristics.

Flux will be launching the 'AdaptMid' model in Autumn/Winter 2022. Ahead of the launch, a limited number of shoes can be pre-ordered in the UK directly through the Versarien products website via the following link: www.versarienproducts.co.uk.

This technology has been developed by the Company's in-house technology teams at University of Manchester and University of Cambridge as part of the GSCALE project and has the potential for multiple elastomer projects.

Neill Ricketts, CEO of Versarien, commented:

"I am delighted to announce the pre-launch of Flux's 'AdaptMid' shoe, enhanced by Versarien's Graphene-Wear™ technology, our first footwear product to market. As more products enhanced using Versarien technology are coming to market, there is now a definite shift within the Company towards commercialisation.

"It is great that our supporters are able to pre-order via our Versarien products website ahead of the full launch by Flux later in the year."

Enquiries:

 

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1594 887204

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

 

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

 

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Henry Wilkinson

Versarien@yellowjerseypr.com

+44 (0)20 3004 9512

 

Notes to Editors:

 

About Versarien

Versarien Plc (AIM: VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

For further information please see: http://www.versarien.com

 

About Flux

Flux LLC was founded in 2020 to create adaptive shoes that that move with rather than against foot movement, by utilising low profile floating cushion pods and tread that contours to the foot.

For further information please see: https://fluxfootwear.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPAFALPAEFA
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.